Time-Limited Initial Therapy for Young, Fit Patients with CLL

N Engl J Med. 2023 May 11;388(19):1812-1813. doi: 10.1056/NEJMe2302557.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Rituximab / administration & dosage
  • Rituximab / adverse effects
  • Rituximab / therapeutic use
  • Time Factors

Substances

  • Rituximab